NCT06245993 Study of Residuals Deformities After Diaphyseal Femoral Fracture in Children Treated by Skin Traction
| NCT ID | NCT06245993 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | EOS |
| Study Type | OBSERVATIONAL |
| Enrollment | 53 participants |
| Start Date | 2023-12-15 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 53 participants in total. It began in 2023-12-15 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diaphyseal femoral fracture in children \<6 years old are treated by the skin traction technique. As demonstrated by numerous studies, given the significant potential for bone remodeling in young children, remodeling (excluding rotational disorder) allows anatomical correction. The aim of this study is to confirm, via EOS imaging, the absence of residual deformities 3 years after the end of treatment in children treated in Amiens hospital department.
Eligibility Criteria
Inclusion Criteria: * \<6 years old at the time of the fracture * treatment by skin zenith traction * femoral shaft fracture, traumatic, unilateral Exclusion Criteria: * Multiple fracture * pathological fracture * history of lower limb fracture * contraindication to zenith traction
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06245993 clinical trial?
This trial is open to participants of all sexes, up to 6 Years, studying EOS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06245993 currently recruiting?
Yes, NCT06245993 is actively recruiting participants. Contact the research team at klein.celine@chu-picardie.fr for enrollment information.
Where is the NCT06245993 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT06245993 clinical trial?
NCT06245993 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 53 participants.